Complications of pamidronate therapy in paediatric osteoporosis.

about

Effects of pamidronate administration on tooth eruption and mandibular growth in new born rats.Effects of Pamidronate on Dental Enamel Formation Assessed by Light Microscopy, Energy-Dispersive X-Ray Analysis, Scanning Electron Microscopy, and Microhardness Testing.

P2860

Q51781971-D6692E03-0652-4E83-B893-4B3738DD705F Q53096539-9BFA079B-9850-4255-9649-717429E84F7B

P2860

Complications of pamidronate therapy in paediatric osteoporosis.

Item

http://www.wikidata.org/entity/Q42583327

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Complications of pamidronate therapy in paediatric osteoporosis.

@en

Complications of pamidronate therapy in paediatric osteoporosis.

@nl

type

Item

label

Complications of pamidronate therapy in paediatric osteoporosis.

@en

Complications of pamidronate therapy in paediatric osteoporosis.

@nl

prefLabel

Complications of pamidronate therapy in paediatric osteoporosis.

@en

Complications of pamidronate therapy in paediatric osteoporosis.

@nl

P1476

Complications of pamidronate therapy in paediatric osteoporosis.

@en

P2093

Sanjay K Chilbule

http://www.w3.org/2001/XMLSchema#string

Vrisha Madhuri

http://www.w3.org/2001/XMLSchema#string

P2860

Bisphosphonate therapy for osteogenesis imperfecta

Genetic heterogeneity in osteogenesis imperfecta.

Addition of pamidronate to chemotherapy for the treatment of osteosarcoma

Bisphosphonates: mechanism of action and role in clinical practice

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.

Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta.

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta.

Intravenous pamidronate in juvenile osteoporosis.

Management of the adverse effects associated with intravenous bisphosphonates.

Bisphosphonates: mode of action and pharmacology.

P2888

s11832-012-0383-5

P304

37-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11832-012-0383-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235757058

http://www.w3.org/2001/XMLSchema#string

P698

23450233

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

P932

3303013

http://www.w3.org/2001/XMLSchema#string

Complications of pamidronate therapy in paediatric osteoporosis.

about

P2860

P2860

Complications of pamidronate therapy in paediatric osteoporosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932